Aflatoxin B1-induced TP53 mutational pattern in normal human cells using the FASAY (Functional Analysis of Separated Alleles in Yeast)

Mutation Research
Vincent PagetMathilde Lechevrel

Abstract

Mutations in the TP53 gene are the most common alterations in human tumours. In hepatocellular carcinoma (HCC) related to exposure to aflatoxin B1, a specific G>T transversion in codon 249 is classically described as a hot spot. However, AFB1 is suspected to be a potent carcinogen in tissues other than the liver. By using the FASAY functional assay in yeast, the present study aimed at depicting the mutational pattern of TP53 in normal human fibroblasts after in vitro exposure to AFB1. Molecular analysis of mutants revealed that codon 245 was the main hot spot, whereas no mutations were found in codon 249. The locations of mutations within GG and GC/CG sequences are well in accordance with AFB1-adduct location data. In our assay with normal human fibroblasts, AFB1 mainly induced G>A transitions, followed by G>T and A>G mutations. This suggests that G>T transversions at codon 249 were likely the result of a selection bias in human HCC rather than a true fingerprint of AFB1 adducts. Indeed, a comparison of the mutation pattern with that found in human HCC excluding codon 249 reveals that the two spectra are quite similar. Furthermore, the similarity between our in vitro spectrum with that identified in AFB1-induced lung tumours in...Continue Reading

References

Mar 20, 1976·British Medical Journal·I Dvorácková
May 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·J M EssigmannG N Wogan
Jan 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·K F MuenchM Z Humayun
Apr 25, 1995·Proceedings of the National Academy of Sciences of the United States of America·J M FlamanJ Benhattar
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·F AguilarP Cerutti
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·N R Soman, G N Wogan
Feb 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·E A BaileyJ M Essigmann
Jun 14, 2002·The Journal of Biological Chemistry·Olga RechkoblitNicholas E Geacintov
Oct 24, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Lihua MingZongtang Sun
Sep 10, 2003·Cancer Letters·Kin-Tak ChanMaria Li Lung
Dec 31, 2005·International Journal of Cancer. Journal International Du Cancer·Xiao-Yang HeJun-Yan Hong
Apr 28, 2006·Journal of Agricultural and Food Chemistry·David GaronPierre Lebailly

❮ Previous
Next ❯

Citations

Dec 15, 2010·Journal of Nucleic Acids·Michael FasulloPatricia A Egner
Aug 12, 2014·Toxicon : Official Journal of the International Society on Toxinology·Rachel ClarkeChristopher T Elliott
Sep 15, 2016·Scientific Reports·Robert J LeeNoam A Cohen
Feb 23, 2010·Journal of Biochemical and Molecular Toxicology·Emna El Golli-BennourHassen Bacha
Sep 3, 2020·EFSA Journal·UNKNOWN EFSA Panel on Contaminants in the Food Chain (CONTAM)Heather Wallace
Jan 6, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Martin Klvana, Urban Bren

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.